Product NDC: | 52584-614 |
Proprietary Name: | Hydralazine Hydrochloride |
Non Proprietary Name: | Hydralazine Hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; Hydralazine Hydrochloride |
Administration Route(s): | INTRAMUSCULAR; INTRAVASCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52584-614 |
Labeler Name: | General Injectables & Vaccines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040388 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111019 |
Package NDC: | 52584-614-01 |
Package Description: | 1 VIAL in 1 BAG (52584-614-01) > 1 mL in 1 VIAL |
NDC Code | 52584-614-01 |
Proprietary Name | Hydralazine Hydrochloride |
Package Description | 1 VIAL in 1 BAG (52584-614-01) > 1 mL in 1 VIAL |
Product NDC | 52584-614 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydralazine Hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVASCULAR |
Start Marketing Date | 20111019 |
Marketing Category Name | ANDA |
Labeler Name | General Injectables & Vaccines, Inc |
Substance Name | HYDRALAZINE HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Arteriolar Vasodilation [PE],Arteriolar Vasodilator [EPC] |